1. Pharmacokinetics of a novel extended half‐life glycoPEGylated factor IX, nonacog beta pegol (N9‐GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials. Issue 4 (24th February 2017) Authors: Tiede, A.; Abdul‐Karim, F.; Carcao, M.; Persson, P.; Clausen, W. H. O.; Kearney, S.; Matsushita, T.; Negrier, C.; Oldenburg, J.; Santagostino, E.; Young, G. Journal: Haemophilia Issue: Volume 23:Issue 4(2017) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗